Bicara Therapeutics BCAX Cash received from option exercises
Cash received from option exercises at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's cash received from option exercises.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bicara Therapeutics's cash received from option exercises?
- Bicara Therapeutics (BCAX) reported cash received from option exercises of $1.58M in Q1 2026.
- How has Bicara Therapeutics's cash received from option exercises changed year-over-year?
- Bicara Therapeutics's cash received from option exercises increased by 243.9% year-over-year, from $460K to $1.58M.
- What is the long-term trend for Bicara Therapeutics's cash received from option exercises?
- Over 2 years (2023 to 2025), Bicara Therapeutics's cash received from option exercises has grown at a 330.6% compound annual growth rate (CAGR), from $149K to $2.76M.
- What does cash received from option exercises mean?
- Represents the cash inflows resulting from employees or directors exercising their vested stock options. It serves as a secondary source of capital and reflects the alignment of employee incentives with shareholder interests.